HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrycja Tudrej Selected Research

Neoplasms (Cancer)

10/2017Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrycja Tudrej Research Topics

Disease

3Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 01/2018
1Breast Neoplasms (Breast Cancer)
04/2024
1Neoplasms (Cancer)
10/2017
1Melanoma (Melanoma, Malignant)
10/2017

Drug/Important Bio-Agent (IBA)

1Cyclin-Dependent Kinase 4IBA
04/2024
1MicroRNAs (MicroRNA)IBA
04/2024
1Phosphotransferases (Kinase)IBA
04/2024
1Hormones (Hormone)IBA
04/2024
1ErbB Receptors (EGF Receptor)IBA
04/2024
1matrigelIBA
07/2018
1Epithelial Cell Adhesion MoleculeIBA
07/2018
1AnthracyclinesIBA
10/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017
1Daunorubicin (Cerubidine)FDA LinkGeneric
10/2017
1WP760IBA
10/2017

Therapy/Procedure

2Therapeutics
01/2019 - 01/2018
1Drug Therapy (Chemotherapy)
10/2017